Market Access Analytics and Insight
Our Market Research & Analysis service is uniquely tailored for…
Our Market Research & Analysis service is uniquely tailored for…
Reimbursement Support, tailored for the complex NHS landscape, aids medical…
Sleep Awareness Week is a global initiative dedicated to highlighting the importance of healthy sleep and raising awareness of sleep disorders that affect millions of people worldwide.
Each year, clinicians, researchers, patients, and healthcare organisations come together to highlight how sleep health influences overall wellbeing, productivity, and long-term health outcomes.
One of the most common yet underdiagnosed sleep conditions is obstructive sleep apnoea (OSA).
Despite affecting millions of people, sleep apnoea often remains undiagnosed for years, leaving patients at risk of serious health complications.
This year’s Sleep Awareness Week highlights the importance of improving access to diagnosis and encouraging innovation in sleep health technologies.
Watch the video above to learn more about sleep apnoea, the challenges facing healthcare systems, and how new technologies are helping transform diagnosis and care.
Sleep apnoea is a sleep disorder in which breathing repeatedly stops and starts during sleep.
The most common type is obstructive sleep apnoea (OSA), which occurs when the muscles in the throat relax and block the airway.
These interruptions can occur dozens or even hundreds of times per night, reducing oxygen levels and fragmenting sleep.
Over time, untreated sleep apnoea can contribute to serious health problems including:
Many people with sleep apnoea remain undiagnosed because symptoms occur during sleep and may go unnoticed for years.
Common symptoms include:
Without diagnosis and treatment, sleep apnoea can significantly affect quality of life and long-term health.
Sleep disorders are increasingly recognised as a major public health challenge.
Obstructive sleep apnoea alone is estimated to affect millions of people in the UK, yet a large proportion remain undiagnosed.
One reason for this is that diagnosis has traditionally relied on overnight sleep studies in specialist clinics, which can create barriers such as:
These challenges mean many patients wait months — or even years — before receiving a confirmed diagnosis.
Sleep Awareness Week provides an opportunity to highlight these gaps and explore how innovation can improve access to care.
Sleep apnoea diagnosis remains a significant challenge for healthcare systems worldwide.
Demand for sleep assessments continues to grow, yet many sleep services are struggling to keep pace.
As highlighted in the video, patients often face:
These barriers can lead to prolonged symptoms and increased health risks for patients.
Improving access to sleep diagnostics is therefore a key priority for healthcare providers and policymakers.
Advances in digital health and diagnostic technology are beginning to transform how sleep apnoea is identified and managed.
New home-based diagnostic devices allow patients to undergo sleep testing in their own homes, reducing the need for overnight hospital visits.
According to NICE, home testing technologies have the potential to increase the number of people diagnosed with sleep apnoea while reducing pressure on sleep clinics.
https://www.nice.org.uk/news/articles/home-testing-devices-could-increase-the-number-of-people-diagnosed-with-sleep-apnoea
Several innovative technologies are already emerging in this space.
Examples include:
NICE has also evaluated digital sleep diagnostic technologies such as WatchPAT and Sunrise as part of its health technology guidance.
https://www.nice.org.uk/guidance/htg735
https://www.nice.org.uk/guidance/htg672
These technologies enable clinicians to assess sleep patterns remotely and support earlier identification of sleep apnoea.
Home diagnostic solutions also make testing more convenient for patients, helping to improve engagement and accessibility.
Beyond diagnostics, researchers are also exploring new technologies to treat sleep apnoea.
One area of investigation involves neuromuscular electrical stimulation of the tongue, delivered through removable devices worn in the mouth during the day.
These devices aim to strengthen tongue muscles and prevent airway collapse during sleep.
However, NICE has highlighted that current evidence on these technologies remains limited, and further research is needed before they can be widely adopted.
https://www.nice.org.uk/researchrecommendation/evidence-on-the-safety-and-efficacy-of-daytime-intraoral-neuromuscular-electrical-tongue-stimulation-using-a-removable-device-for-obstructive-sleep-apnoea-is-inadequate-in-quality-and-quantity-so-this-procedure-should-be-used-only-in-research-find-out-wha
This highlights the continued need for innovation, clinical research, and collaboration to develop effective new approaches to sleep apnoea care.
Sleep apnoea presents a growing challenge for healthcare systems, but it also represents a major opportunity for innovation.
New technologies have the potential to transform how sleep disorders are diagnosed, monitored, and treated.
Solutions that could improve sleep apnoea care include:
At Health Analytical Solutions, we believe that collaboration between MedTech innovators, clinicians, NHS partners, and research organisations is essential to accelerate progress in sleep health.
That’s why we are calling on innovators, researchers, and healthcare leaders to come forward with solutions that could improve the diagnosis and treatment of sleep apnoea.
This could include technologies that:
By bringing together expertise from across healthcare and technology, we can help identify solutions that make sleep care more accessible, more efficient, and more patient-centred.
If you are working on innovations that could improve sleep apnoea diagnosis or treatment, we encourage you to connect with us at enquiry@healthanalyticalsolutions.co.uk to explore opportunities for collaboration.
Innovation starts with awareness — and Sleep Awareness Week is the perfect moment to take action.
© Health Analytical Solutions 2026